Pepe, P.; Roscigno, M.; Pepe, L.; Panella, P.; Tamburo, M.; Marletta, G.; Savoca, F.; Candiano, G.; Cosentino, S.; Ippolito, M.;
et al. Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols? J. Clin. Med. 2022, 11, 3473.
https://doi.org/10.3390/jcm11123473
AMA Style
Pepe P, Roscigno M, Pepe L, Panella P, Tamburo M, Marletta G, Savoca F, Candiano G, Cosentino S, Ippolito M,
et al. Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols? Journal of Clinical Medicine. 2022; 11(12):3473.
https://doi.org/10.3390/jcm11123473
Chicago/Turabian Style
Pepe, Pietro, Marco Roscigno, Ludovica Pepe, Paolo Panella, Marinella Tamburo, Giulia Marletta, Francesco Savoca, Giuseppe Candiano, Sebastiano Cosentino, Massimo Ippolito,
and et al. 2022. "Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?" Journal of Clinical Medicine 11, no. 12: 3473.
https://doi.org/10.3390/jcm11123473
APA Style
Pepe, P., Roscigno, M., Pepe, L., Panella, P., Tamburo, M., Marletta, G., Savoca, F., Candiano, G., Cosentino, S., Ippolito, M., Tsirgiotis, A., & Pennisi, M.
(2022). Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols? Journal of Clinical Medicine, 11(12), 3473.
https://doi.org/10.3390/jcm11123473
